BIOMAT Database Logo BIOMAT Database Logo

Huntington's disease and its animal model: alterations in kainic acid binding. 1979

K Beaumont, and Y Maurin, and T D Reisine, and J Z Fields, and E Spokes, and E D Bird, and H I Yamamura

UI MeSH Term Description Entries
D007608 Kainic Acid (2S-(2 alpha,3 beta,4 beta))-2-Carboxy-4-(1-methylethenyl)-3-pyrrolidineacetic acid. Ascaricide obtained from the red alga Digenea simplex. It is a potent excitatory amino acid agonist at some types of excitatory amino acid receptors and has been used to discriminate among receptor types. Like many excitatory amino acid agonists it can cause neurotoxicity and has been used experimentally for that purpose. Digenic Acid,Kainate,Acid, Digenic,Acid, Kainic
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008297 Male Males
D011699 Putamen The largest and most lateral of the BASAL GANGLIA lying between the lateral medullary lamina of the GLOBUS PALLIDUS and the EXTERNAL CAPSULE. It is part of the neostriatum and forms part of the LENTIFORM NUCLEUS along with the GLOBUS PALLIDUS. Nucleus Putamen,Nucleus Putamens,Putamen, Nucleus,Putamens,Putamens, Nucleus
D011759 Pyrrolidines Compounds also known as tetrahydropyridines with general molecular formula (CH2)4NH. Tetrahydropyridine,Tetrahydropyridines
D002421 Caudate Nucleus Elongated gray mass of the neostriatum located adjacent to the lateral ventricle of the brain. Caudatus,Nucleus Caudatus,Caudatus, Nucleus,Nucleus, Caudate
D002795 Choline O-Acetyltransferase An enzyme that catalyzes the formation of acetylcholine from acetyl-CoA and choline. EC 2.3.1.6. Choline Acetylase,Choline Acetyltransferase,Acetylase, Choline,Acetyltransferase, Choline,Choline O Acetyltransferase,O-Acetyltransferase, Choline
D003342 Corpus Striatum Striped GRAY MATTER and WHITE MATTER consisting of the NEOSTRIATUM and paleostriatum (GLOBUS PALLIDUS). It is located in front of and lateral to the THALAMUS in each cerebral hemisphere. The gray substance is made up of the CAUDATE NUCLEUS and the lentiform nucleus (the latter consisting of the GLOBUS PALLIDUS and PUTAMEN). The WHITE MATTER is the INTERNAL CAPSULE. Lenticular Nucleus,Lentiform Nucleus,Lentiform Nuclei,Nucleus Lentiformis,Lentiformis, Nucleus,Nuclei, Lentiform,Nucleus, Lenticular,Nucleus, Lentiform,Striatum, Corpus
D004195 Disease Models, Animal Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases. Animal Disease Model,Animal Disease Models,Disease Model, Animal
D006816 Huntington Disease A familial disorder inherited as an autosomal dominant trait and characterized by the onset of progressive CHOREA and DEMENTIA in the fourth or fifth decade of life. Common initial manifestations include paranoia; poor impulse control; DEPRESSION; HALLUCINATIONS; and DELUSIONS. Eventually intellectual impairment; loss of fine motor control; ATHETOSIS; and diffuse chorea involving axial and limb musculature develops, leading to a vegetative state within 10-15 years of disease onset. The juvenile variant has a more fulminant course including SEIZURES; ATAXIA; dementia; and chorea. (From Adams et al., Principles of Neurology, 6th ed, pp1060-4) Huntington Chorea,Juvenile Huntington Disease,Akinetic-Rigid Variant of Huntington Disease,Chorea, Chronic Progressive Hereditary (Huntington),Chronic Progressive Hereditary Chorea (Huntington),Huntington Chronic Progressive Hereditary Chorea,Huntington Disease, Akinetic-Rigid Variant,Huntington Disease, Juvenile,Huntington Disease, Juvenile-Onset,Huntington Disease, Late Onset,Huntington's Chorea,Huntington's Disease,Juvenile-Onset Huntington Disease,Late-Onset Huntington Disease,Progressive Chorea, Chronic Hereditary (Huntington),Progressive Chorea, Hereditary, Chronic (Huntington),Akinetic Rigid Variant of Huntington Disease,Chorea, Huntington,Chorea, Huntington's,Huntington Disease, Akinetic Rigid Variant,Huntington Disease, Juvenile Onset,Huntington Disease, Late-Onset,Juvenile Onset Huntington Disease,Late Onset Huntington Disease

Related Publications

K Beaumont, and Y Maurin, and T D Reisine, and J Z Fields, and E Spokes, and E D Bird, and H I Yamamura
Kainic acid animal model predicts therapeutic agents in Huntington's chorea.
January 1979, Transactions of the American Neurological Association,
K Beaumont, and Y Maurin, and T D Reisine, and J Z Fields, and E Spokes, and E D Bird, and H I Yamamura
Kainic acid binding in human caudate nucleus: effect of Huntington's disease.
October 1979, Neuroscience letters,
K Beaumont, and Y Maurin, and T D Reisine, and J Z Fields, and E Spokes, and E D Bird, and H I Yamamura
3-Nitropropionic acid animal model and Huntington's disease.
May 1997, Neuroscience and biobehavioral reviews,
K Beaumont, and Y Maurin, and T D Reisine, and J Z Fields, and E Spokes, and E D Bird, and H I Yamamura
Amino acid neurotransmitter abnormalities in Huntington's disease and the quinolinic acid animal model of Huntington's disease.
December 1987, Brain : a journal of neurology,
K Beaumont, and Y Maurin, and T D Reisine, and J Z Fields, and E Spokes, and E D Bird, and H I Yamamura
Decreased receptor-binding sites for kainic acid in brains of patients with Huntington's disease.
February 1981, Biological psychiatry,
K Beaumont, and Y Maurin, and T D Reisine, and J Z Fields, and E Spokes, and E D Bird, and H I Yamamura
Metabolic alterations in an animal model of Huntington's disease using the 14C-deoxyglucose method.
January 1980, Journal of neural transmission. Supplementum,
K Beaumont, and Y Maurin, and T D Reisine, and J Z Fields, and E Spokes, and E D Bird, and H I Yamamura
An animal model for Huntington's disease.
April 1979, Biological psychiatry,
K Beaumont, and Y Maurin, and T D Reisine, and J Z Fields, and E Spokes, and E D Bird, and H I Yamamura
Loss of striatal serotonin synaptic receptor binding induced by kainic acid lesions: correlations with Huntington's Disease.
April 1977, Journal of neurochemistry,
K Beaumont, and Y Maurin, and T D Reisine, and J Z Fields, and E Spokes, and E D Bird, and H I Yamamura
Striatal circuit development and its alterations in Huntington's disease.
November 2020, Neurobiology of disease,
K Beaumont, and Y Maurin, and T D Reisine, and J Z Fields, and E Spokes, and E D Bird, and H I Yamamura
Selective loss of [3H]kainic acid and [3H]AMPA binding in layer VI of frontal cortex in Huntington's disease.
May 1994, Experimental neurology,
Copied contents to your clipboard!